Confederated Tribes of the Goshute Reservation
Confederated Tribes of the Goshute Reservation was paid $15.11M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 33% of everything it billed.
SALT LAKE CITY, UT 84111
Next to other Clinical Medical Laboratory providers in Utah
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,573 | $3.27M | |
| 2019 | 10,948 | $1.09M | |
| 2020 | 9,195 | $823K | |
| 2021 | 16,787 | $1.59M | |
| 2022 | 13,868 | $2.01M | |
| 2023 | 21,469 | $2.86M | |
| 2024incomplete | 16,523 | $3.45M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 33% | 10,120 | 8,184 | $4.98M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 11% | 4,478 | 4,367 | $1.59M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.8% | 9,613 | 7,914 | $1.48M |
| 36415 | Collection of venous blood by venipuncture | 7.1% | 11,133 | 10,317 | $1.07M |
| 80305 | 5.8% | 9,242 | 7,472 | $878K | |
| 84443 | Thyroid stimulating hormone (TSH) | 5.5% | 5,465 | 5,298 | $833K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.3% | 6,218 | 6,027 | $503K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 2,793 | 2,698 | $471K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.1% | 944 | 810 | $324K |
| 81003 | 2.1% | 1,725 | 1,628 | $322K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 589 | 519 | $299K |
| 80074 | 1.9% | 982 | 953 | $281K |
38 more codes
| 80061 | Lipid panel | 1.7% | 5,248 | $251K |
| 86703 | 1.6% | 963 | $245K | |
| 85027 | 1.5% | 4,108 | $228K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.2% | 273 | $176K |
| 36416 | 1.1% | 770 | $166K | |
| 84436 | <1% | 2,056 | $128K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,660 | $120K |
| 99000 | <1% | 608 | $93K | |
| 83735 | <1% | 767 | $74K | |
| 82043 | <1% | 403 | $56K | |
| 82728 | <1% | 2,224 | $56K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 232 | $56K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 79 | $53K |
| 82607 | <1% | 2,356 | $49K | |
| 82746 | <1% | 2,325 | $45K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 142 | $44K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 60 | $41K |
| 81025 | <1% | 193 | $40K | |
| 82248 | <1% | 64 | $31K | |
| 83014 | <1% | 57 | $26K | |
| 86376 | <1% | 816 | $18K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 54 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 79 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 66 | $12K |
| 83655 | <1% | 13 | $7K | |
| 84439 | <1% | 2,525 | $6K | |
| 86800 | <1% | 818 | $5K | |
| 82570 | <1% | 399 | $5K | |
| 83550 | <1% | 2,226 | $4K | |
| 84153 | <1% | 40 | $2K | |
| 81015 | <1% | 221 | $2K | |
| 0240U | <1% | 23 | $2K | |
| 85018 | <1% | 82 | $2K | |
| 84480 | <1% | 819 | $1K | |
| 85652 | <1% | 39 | $1K | |
| 83540 | <1% | 2,226 | $1K | |
| 82962 | <1% | 13 | $958.00 | |
| 84100 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Confederated Tribes of the Goshute Reservation | Salt Lake City, UT | $13.89M |
| Confederated Tribes of the Goshute Reservation | Salt Lake City, UT | $6.42M |
| Confederated Tribes of the Goshute Reservation | Salt Lake City, UT | $4.54M |
| Sacred Circle Healthcare | Salt Lake City, UT | $247K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.